Contagion Community

Cidara Therapeutics is developing a new echinocandin called Rezafungin that's shown promise in clinical trials. Cidara is also developing a new anti-viral technology which isn't a vaccine, but could provide universal flu protection on a different basis. 

 

We talked to CEO Jeff Stein, PhD, about these therapies. 

 

After speaking with Dr. Stein, we hone in on Rezafungin in a chat with George Thompson, MD, associate professor of clinical medicine at the UC Davis School of Medicine. 

 

Dr. Thompson is an infectious disease clinician and an expert in the mycology field. He was an investigator in Cidara’s phase two trial of Rezafungin and is involved in the currently being enrolled phase three trial.

Follow Contagion® on Twitter.

Music credit: Joseph McDade

Listen for a daily COVID-19 update.

Listen for a daily COVID-19 update.

Assistant Editor Grant Gallagher provides a daily COVID-19 update.

In this episode of Contagion® Connect, we'll bring you a voice from Nanjing, China. Seth Bourg is an American physics teacher who has been living in the city since August. He'll give us his unique insight on life under quarantine there, not only as an American, but as someone with the experience to compare the interruption to society with New Orleans during Hurricane Katrina.

For an interview transcript, visit Contagion® here.

Music credit: Joseph McDade

Welcome to Contagion® Connect. This podcast will bring you expert perspectives on trending infectious disease topics. 

 

First, we'll speak to John Johnson, project lead for Ebola vaccination in the Democratic Republic of the Congo with Médecins Sans Frontières France, for a perspective on how the new availability of vaccines has shaped the response to the ongoing epidemic compared to the West African Ebola outbreak.

Then, we'll speak with microbiologist Jason Kindrachuk, PhD, about his experience in Liberia during the West African epidemic. Kindrachuk is also an expert on current research pertaining to lasting effects in Ebola survivors, so we'll speak to him for a clinical perspective on what the future holds for those who survive the disease.

A transcript of the interview is available on Contagionlive.com

Follow Jason Kindrachuk, MSF, and Contagion® on Twitter.

Music credit: Joseph McDade

Welcome to Contagion® Connect. This new podcast will bring you expert perspectives on trending infectious disease topics.

In this episode, we feature a conversation with Timothy Ray Brown recorded at ANAC 2019 in Portland, Oregon. Brown became the first person to be cured of HIV after received a stem-cell transplant to treat leukemia. At first, he desired to remain anonymous and was referred to as the “Berlin Patient.” However, in 2010, Brown came forward and has become an advocate for people living with HIV. He hopes to see the day when all individuals when HIV can be cured safely.

https://www.contagionlive.com/news/contagion-connect-episode-4-timothy-ray-browns-advocacy-for-hiv-cure-research

Paul Abrams, MBA, director of Health Care Specialty Group at MJH Life Sciences, speaks with Vaibhav Singh, co-founder and CEO of Circle of Life, about his company’s product, Zevac, which aims to help clinicians make more informed prescribing decisions.

For a full transcript visit https://www.contagionlive.com/.

Welcome to Contagion® Connect. This new podcast will bring you expert perspectives on trending infectious disease topics. 

 

In this episode, we take a dual look at the recently announced changes to antibiotic reimbursements from the Centers for Medicare and Medicaid Services. First, we’ll speak to Dr. Susan Davis, an infectious disease pharmacist, about the impact from a clinician standpoint. Then we'll talk to Larry Edwards, CEO of Tetraphase Pharmaceuticals, for an industry perspective.

A transcript of the interview is available on ContagionLive.com.

Follow Contagion® on Twitter.

Music credit: Joseph McDade

Welcome to Contagion® Connect. This new podcast will bring you expert perspectives on trending infectious disease topics. 

 

In this episode, we are joined by Alexandra L. Phelan, SJD, LLM, LLB, from the Georgetown University Center for Global Health Science and Security. We will be discussing an editorial published in Nature regarding the impact of pandemic bonds on the ongoing Ebola outbreak and the Democratic Republic of the Congo.

A transcript of the interview is available on ContagionLive.com.

Follow Dr. Phelan and Contagion® on Twitter.

Music credit: Joseph McDade